Evidence map›Paper›PMID 34607080›Full record

ArticleInfectious diseases now2022

Comparison of the first and second waves of coronavirus disease in Toulouse, France.

Aurelie Jourdes, Margaux Lafaurie, Guillaume Moulis, Pierre Delobel, Marie Faruch, Agnes Sommet, Guillaume Martin-Blondel

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases now, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aurelie JourdesService des maladies infectieuses et tropicales, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France. Electronic address: jourdes.a@chu-toulouse.fr.
Margaux LafaurieCentre d'investigation clinique 1436, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France; Service de pharmacologie médicale et technique, CHU de Toulouse, 37, allées Jules-Guesde, 31000 Toulouse, France.
Guillaume MoulisService de médecine interne, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France.
Pierre DelobelService des maladies infectieuses et tropicales, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France.
Marie FaruchService de radiologie et imagerie médicale, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France.
Agnes SommetCentre d'investigation clinique 1436, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France; Service de pharmacologie médicale et technique, CHU de Toulouse, 37, allées Jules-Guesde, 31000 Toulouse, France.
Guillaume Martin-BlondelService des maladies infectieuses et tropicales, CHU de Toulouse Purpan, Place du Dr Joseph-Baylac, 31300 Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19FranceHumansSARS-CoV-2COVID-19EpidemiologySARS-CoV-2

Identifiers

PMID34607080
PMCPMC8485717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.